Statistics from Altmetric.com
Renehan1 argues that we inappropriately used the Kaplan–Meier method to estimate the risk of metachronous colorectal cancer, and instead recommends a competing risk analysis.2 While we agree that a competing risk analysis is a valid technique, we claim that the Kaplan–Meier estimate is also valid, and in this setting more appropriate.
We have reported the cumulative risk of metachronous colorectal cancer following segmental surgery for a first colon cancer for carriers of mutations in mismatch repair genes.3 Using …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.